The Right Ventricular Failure Risk Score. A Pre-Operative Tool for Assessing the Risk of Right Ventricular Failure in Left Ventricular Assist Device Candidates

Journal of the American College of Cardiology

Volumn 51, Issue 22, 2008, Pages 2163-2172

  Matthews, Jennifer Cowger ^a   Koelling, Todd M ^a   Pagani, Francis D ^a   Aaronson, Keith D ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CREATININE; DOBUTAMINE; DOPAMINE; HYPERTENSIVE AGENT; INOTROPIC AGENT; LIDOCAINE; MILRINONE; NITRIC OXIDE; NORADRENALIN; PHENYLEPHRINE; VASOPRESSIN;

ADULT; AREA UNDER THE CURVE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; ASSISTED CIRCULATION; BILIRUBIN BLOOD LEVEL; CARDIOVASCULAR RISK; CONFIDENCE INTERVAL; CREATININE BLOOD LEVEL; DATA BASE; ELECTROCARDIOGRAM; FEMALE; HEART ASSIST DEVICE; HEART FAILURE; HEMODYNAMIC PARAMETERS; HOSPITAL DISCHARGE; HUMAN; IMPLANT; LOG RANK TEST; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; SCORING SYSTEM; STRATIFICATION; SURVIVAL RATE;

DATABASES AS TOPIC; FEMALE; HEALTH STATUS INDICATORS; HEART FAILURE; HEART VENTRICLES; HEART-ASSIST DEVICES; HEMODYNAMICS; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; PHENYLEPHRINE; PREOPERATIVE CARE; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; ROC CURVE; VASOPRESSINS;

EID: 44049094013     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2008.03.009     Document Type: Article

References (18)

1. Dang N.C., Topkara V.K., Mercando M., et al. Right heart failure after left ventricular assist device implantation in patients with chronic congestive heart failure. J Heart Lung Transplant 25 (2006) 1-6
2. Kavarana M.N., Pessin-Minsley M.S., Urtecho J., et al. Right ventricular dysfunction and organ failure in left ventricular assist device recipients: a continuing problem. Ann Thoracic Surg 73 (2002) 745-750
3. Deng M.C., Edwards L.B., Hertz M.I., et al. Mechanical Circulatory Support Device Database of the International Society for Heart and Lung Transplantation: Third Annual Report-2005. J Heart Lung Transplant 24 (2005) 1182-1187
4. Farrar D.J., Hill J.D., Pennington D.G., et al. Preoperative and postoperative comparison of patients with univentricular and biventricular support with the Thoratec ventricular assist device as a bridge to cardiac transplantation. J Thorac Cardiovasc Surg 113 (1997) 202-209
5. Fukamachi K., McCarthy P.M., Smedira N.G., et al. Preoperative risk factors for right ventricular failure after implantable left ventricular assist device insertion. Ann Thoracic Surg 68 (1999) 2181-2184
6. Kormos R.L., Gasior T.A., Kawai A., et al. Transplant candidate's clinical status rather than right ventricular function defines need for univentricular versus biventricular support. J Thorac Cardiovasc Surg 111 (1996) 773-782
7. Morgan J.A., John R., Lee B.J., Oz M.C., and Naka Y. Is severe right ventricular failure in left ventricular assist device recipients a risk factor for unsuccessful bridging to transplant and post-transplant mortality. Ann Thorac Surg 77 (2004) 859-863
8. Levin H., Burkhoff D., and Chen J. Right ventricular performance (but not outflow resistance) is a major preoperative determinant of right heart failure in patients with chronic heart failure who receive a left ventricular assist device. J Am Coll Cardiol Suppl A (1994) 484A
9. Nakatani S., Thomas J.D., Savage R.M., et al. Prediction of right ventricular dysfunction after left ventricular assist device implantation. Circulation 94 (1996) 216-221
10. Ochiai Y., McCarthy P.M., Smedira N.G., et al. Predictors of severe right ventricular failure after implantable left ventricular assist device insertion: analysis of 245 patients. Circulation 106 (2002) 198-202
11. Santambrogio L., Bianchi T., Fuardo M., et al. Right ventricular failure after left ventricular assist device insertion: preoperative risk factors. Interactive Cardiovasc Thorac Surg 5 (2006) 379-382
12. Schenk S., McCarthy P.M., Blackstone E.H., et al. Duration of inotropic support after left ventricular assist device implantation: risk factors and impact on outcome. J Thorac Cardiovasc Surg 131 (2006) 447-454
13. Hanley J.A., and McNeil B.J. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 148 (1983) 839-843
14. Schmid C., and Radovancevic B. When should we consider right ventricular support?. Thorac Cardiovasc Surg 50 (2002) 204-207
15. Aaronson K.D., Schwartz J.S., Chen T.-M., et al. Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. Circulation 95 (1997) 2660-2667
16. Oz M., Argenziano M., Catanese K.A., et al. Bridge experience with long-term implantable left ventricular assist devices: are they an alternative to transplantation?. Circulation 95 (1997) 1844-1852
17. Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS). Practical Web-based Data Entry Training with INTERMACS Support (2005). Available at http://www.intermacs.org/downloads/admin_training.ppt#59. Accessed December 1, 2007.
18. Argenziano M., Choudhri A.F., Moazami N., et al. Randomized, double-blind trial of inhaled nitric oxide in LVAD recipients with pulmonary hypertension. Ann Thorac Surg 65 (1998) 340-345